Clinical Unit for Research Trials in Skin - MGH
Boston, Massachusetts, 02114, United States
NCT Number: NCT00836342
The purpose of this study is to determine the difference of skin carotenoid levels between subjects with previous squamous cell carcinomas (SCC), subjects with previous basal cell carcinomas (BCC) and a control group.
Looking for future studies?
Notify Me50 year–75 year
All sexes
Observational
Boston, Massachusetts, 02114, United States
There has been experimental and clinical research evaluating association of different carotenoids and incidence of malignancies, including Non- Melanoma Skin Cancer (NMSC). An easy and inexpensive way to determine which subjects would benefit from supplementation with carotenoids or retinoids could be the measurement of skin carotenoid levels.The least invasive way to perform it is through Raman spectroscopy which is a technique that uses a laser light that can be used to quantify carotenoids on the skin. We will compare the skin carotenoid levels of subjects with previous history of SCC or BCC and subjects without history of previous NMSC.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline
Mean carotenoid levels in subjects with a history of squamous cell carcinoma were compared to mean carotenoid levels in control subjects without a history of nonmelanoma skin cancer.
Time frame: baseline
Time frame: baseline
Massachusetts General Hospital
Other
Comparison of Skin Carotenoid Levels Between Subjects With History of Cutaneous Squamous Cell Carcinoma and Subjects With History of Basal Cell Carcinoma Versus a Control Group
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03509467
Basal Cell Cancer, Basal Cell Carcinoma
Tampa, Florida, United States
View Trial DetailsNCT05648604
Basal Cell Carcinoma, Behavior
Tucson, Arizona, United States
View Trial DetailsNCT00046189
Basal Cell Carcinoma, Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT03237013
Basal Cell Carcinoma, Carcinoma
San Diego, California, United States
View Trial Details